CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
83 hedge funds and large institutions have $200M invested in CTI BioPharma Corp. (DE) Common Stock in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
42% more capital invested
Capital invested by funds: $142M → $200M (+$59M)
24% more funds holding
Funds holding: 67 → 83 (+16)
Holders
83
Holding in Top 10
2
Calls
$512K
Puts
$217K
Top Buyers
| 1 | +$11.8M | |
| 2 | +$3.99M | |
| 3 | +$2.36M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.56M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.18M |
Top Sellers
| 1 | -$5.44M | |
| 2 | -$1.69M | |
| 3 | -$806K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$767K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$747K |